D25 Leiomyoma of uterus

Name of the Condition

• Leiomyoma of uterus

Summary

Leiomyoma of the uterus, commonly known as uterine fibroids, is a non-cancerous tumor that originates from the smooth muscle tissue of the uterus. These growths are benign and can vary in size, number, and location within the uterine structure. Many women with leiomyomas experience no symptoms, while others may have mild to severe manifestations depending on the fibroid's characteristics.

Causes

The exact cause of uterine leiomyomas is not fully understood, but hormonal factors, particularly estrogen and progesterone, are believed to play a significant role in their development and growth. Genetic predisposition and other molecular factors may also contribute to their formation.

Risk Factors

• Age (most common in women of reproductive age, typically 30–50 years)
• Family history of uterine fibroids
• Obesity
• Ethnicity (higher prevalence in African-American women)
• Dietary factors, such as high red meat consumption and low intake of fruits/vegetables

Symptoms

• Heavy or prolonged menstrual bleeding
• Pelvic pain or pressure
• Frequent urination or urinary urgency
• Constipation or difficulty with bowel movements
• Lower back pain or leg discomfort
• Abdominal bloating or swelling

Diagnosis

Diagnosis typically involves a combination of clinical evaluation and imaging studies. A pelvic examination may reveal an enlarged or irregularly shaped uterus. Transvaginal or abdominal ultrasound is commonly used to visualize fibroids, while MRI may provide more detailed information about size, number, and location. In some cases, hysteroscopy or sonohysterography may be performed to assess fibroids within the uterine cavity.

Treatment Options

• Medications: Hormonal therapies (e.g., GnRH agonists) to reduce fibroid size or control symptoms like heavy bleeding.
• Minimally invasive procedures: Uterine artery embolization (UAE) to block blood flow to fibroids, or MRI-guided focused ultrasound surgery (FUS) to destroy fibroid tissue.
• Surgical options: Myomectomy (removal of fibroids while preserving the uterus) or hysterectomy (removal of the uterus) for severe or persistent symptoms.

Prognosis and Follow-Up

Most leiomyomas are benign and do not pose a significant health risk. Symptoms often stabilize or improve with treatment, though new fibroids may develop over time. Regular follow-up with a healthcare provider is recommended to monitor fibroid growth and manage symptoms, especially for women planning pregnancy or experiencing worsening symptoms.

Complications

• Anemia due to chronic heavy bleeding
• Infertility or pregnancy complications (e.g., miscarriage, preterm labor)
• Urinary tract obstruction or kidney dysfunction from large fibroids
• Pelvic pain or discomfort

Lifestyle & Prevention

• Maintain a healthy weight through balanced diet and regular exercise.
• Limit red meat intake and increase consumption of fruits, vegetables, and whole grains.
• Manage stress and monitor menstrual patterns for changes.
• Discuss family history with a healthcare provider to assess individual risk.

When to Seek Professional Help

Seek medical attention if you experience:

• Sudden, severe pelvic pain
• Heavy bleeding that soaks through pads/tampons hourly for several hours
• Difficulty urinating or bowel movements
• Unexplained weight loss or fever
• Persistent or worsening symptoms despite treatment

Tips for Medical Coders

When coding for leiomyoma of the uterus (ICD-10-CM code D25), ensure documentation specifies the fibroid's location (e.g., submucous, intramural, subserosal) if available, as this may impact code specificity. Note any associated symptoms (e.g., bleeding, pain) or complications (e.g., anemia) to support additional coding. Verify that the diagnosis is clearly documented and linked to the appropriate encounter type.